Bosh sahifaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
33,65 $
Seans yopilganidan keyin:(0,00%)0,00
33,65 $
Yopilgan:26-iyn, 16:01:22 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
32,71 $
Kunlik diapazon
32,59 $ - 33,70 $
Yillik diapazon
23,42 $ - 62,58 $
Bozor kapitalizatsiyasi
1,95 mlrd USD
Oʻrtacha hajm
601,42 ming
Narx/foyda
2,98
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 8,73 mln | 6,56% |
Joriy xarajat | 41,53 mln | 33,90% |
Sof foyda | -89,29 mln | -9,49% |
Sof foyda marjasi | -1,02 ming | -2,75% |
Har bir ulushga tushum | -1,55 | -6,90% |
EBITDA | -105,35 mln | -16,12% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 893,38 mln | 49,40% |
Jami aktivlari | 1,56 mlrd | 83,06% |
Jami passivlari | 88,99 mln | -15,88% |
Umumiy kapital | 1,47 mlrd | — |
Tarqatilgan aksiyalar | 57,92 mln | — |
Narxi/balansdagi bahosi | 1,29 | — |
Aktivlardan daromad | -16,56% | — |
Kapitaldan daromad | -17,10% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -89,29 mln | -9,49% |
Operatsiyalardan naqd pul | -111,49 mln | -11,64% |
Sarmoyadan naqd pul | 112,59 mln | -9,61% |
Moliyadan naqd pul | 1,62 mln | -72,39% |
Naqd pulning sof oʻzgarishi | 2,72 mln | -91,11% |
Boʻsh pul | -87,33 mln | -20,46% |
Haqida
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Tashkil etilgan
2008
Sayt
Xodimlar soni
487
